Related references
Note: Only part of the references are listed.A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score
Ziad Hijazi et al.
EUROPEAN HEART JOURNAL (2018)
Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference
Dipak Kotecha et al.
EUROPACE (2018)
Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care
Igor Diemberger et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report fromthe EURObservational research programme pilot survey on atrial fibrillation
Marco Proietti et al.
EUROPACE (2017)
Adverse cardiovascular outcomes in atrial fibrillation: Validation of the new 2MACE risk score
Marija Polovina et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
The future of atrial fibrillation management: integrated care and stratified therapy
Paulus Kirchhof
LANCET (2017)
The ABC pathway: an integrated approach to improve AF management
Gregory Y. H. Lip
NATURE REVIEWS CARDIOLOGY (2017)
Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation
Keith A. A. Fox et al.
BMJ OPEN (2017)
Predictive role of CHA2DS2-VASc score for cardiovascular events and death in patients with arterial hypertension and stable sinus rhythm
Carmine Mazzone et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2017)
Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis
Vidar Ruddox et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2017)
Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation
Jose Miguel Rivera-Caravaca et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
Bleeding Risk Scores in Atrial Fibrillation and Venous Thromboembolism
Hanis Zulkifly et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial
Marco Proietti et al.
CLINICAL RESEARCH IN CARDIOLOGY (2016)
Causes of Death and Influencing Factors in Patients with Atrial Fibrillation
Laurent Fauchier et al.
AMERICAN JOURNAL OF MEDICINE (2016)
Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation
Jonas Oldgren et al.
CIRCULATION (2016)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof et al.
EUROPEAN HEART JOURNAL (2016)
Causes of Death in Anticoagulated Patients With Atrial Fibrillation
Antonio Gomez-Outes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
Ziad Hijazi et al.
LANCET (2016)
Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation
Line Melgaard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society
Craig T. January et al.
CIRCULATION (2014)
Stroke and Bleeding Risk in Atrial Fibrillation: Navigating the Alphabet Soup of Risk-Score Acronyms (CHADS2, CHA2DS2-VASc, R2CHADS2, HAS-BLED, ATRIA, and More)
Mikhail S. Dzeshka et al.
CLINICAL CARDIOLOGY (2014)
Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores
L. Brent Mitchell et al.
HEART (2014)
A New Risk Scheme to Predict Ischemic Stroke and Other Thromboembolism in Atrial Fibrillation: The ATRIA Study Stroke Risk Score
Daniel E. Singer et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
A New Risk Scheme to Predict Warfarin-Associated Hemorrhage The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study
Margaret C. Fang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation The Euro Head Survey
Ron Pisters et al.
CHEST (2010)
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
Gregory Y. H. Lip et al.
CHEST (2010)
Progression From Paroxysmal to Persistent Atrial Fibrillation Clinical Correlates and Prognosis
Cees B. de Vos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
A re-evaluation of random-effects meta-analysis
Julian P. T. Higgins et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY (2009)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Selecting patients with atrial fibrillation for anticoagulation - Stroke risk stratification in patients taking aspirin
BF Gage et al.
CIRCULATION (2004)
Share Paper
